medicines bill
Clinigen launches ‘What is Possible?’ campaign on Rare Disease Day to accelerate access to medicines
There are over 7,000 rare diseases impacting more than 300 million people globally
EU cross-border healthcare
The clock is ticking to improve access to gene and cell therapies for rare diseases
Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant
Grant will help accelerate medicine registration in low/middle-income countries
NICE International relaunches, will offer advisory services
Meets growing demand from global health and social care organisations
Comment: the new UK pricing deal – welcome news, but lessons to be learned
Leslie Galloway, chairman of EMIG reflects on the new UK government-pharma industry pricing agreement
UK unveils plans for bigger medicines price squeeze
Company payments to government would rise steeply to 2021
UK appoints pharma veteran to ‘streamline’ NHS costs
Steve Oldfield will take up new chief commercial officer role at the Department of Health
UK government tables bill on medicine pricing reforms
New scheme proposes single payment mechanism for old and new drugs alike
Pharma must ‘create new social contract’
New task force established in UK to assess public’s view of the value and risk of medicines
GSK found UK’s drug pricing changes a tough sell
Firm's chief executive met with the government to question the last PPRS update